Found: 61
Select item for more details and to access through your institution.
A Self‐Digitization Dielectrophoretic (SD‐DEP) Chip for High‐Efficiency Single‐Cell Capture, On‐Demand Compartmentalization, and Downstream Nucleic Acid Analysis.
- Published in:
- Angewandte Chemie, 2018, v. 130, n. 35, p. 11548, doi. 10.1002/ange.201807314
- By:
- Publication type:
- Article
Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 5, p. 945, doi. 10.1007/s00432-018-2604-x
- By:
- Publication type:
- Article
AKR1C3 expression in T acute lymphoblastic leukemia/lymphoma for clinical use as a biomarker.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-09697-6
- By:
- Publication type:
- Article
A Self‐Digitization Dielectrophoretic (SD‐DEP) Chip for High‐Efficiency Single‐Cell Capture, On‐Demand Compartmentalization, and Downstream Nucleic Acid Analysis.
- Published in:
- Angewandte Chemie International Edition, 2018, v. 57, n. 35, p. 11378, doi. 10.1002/anie.201807314
- By:
- Publication type:
- Article
Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) study.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
MicroRNA Discovery and Profiling in Human Embryonic Stem Cells by Deep Sequencing of Small RNA Libraries.
- Published in:
- Stem Cells, 2008, v. 26, n. 10, p. 2496, doi. 10.1634/stemcells.2008-0356
- By:
- Publication type:
- Article
The (near) miracle of therapy in chronic myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 5, p. 919, doi. 10.1111/bjh.18956
- By:
- Publication type:
- Article
The reality of cancer treatment in a developing country: the effects of delayed TKI treatment on survival, cytogenetic and molecular responses in chronic myeloid leukaemia patients.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 3, p. 420, doi. 10.1111/bjh.13843
- By:
- Publication type:
- Article
Imatinib 800 mg daily induces deeper molecular responses than imatinib 400 mg daily: results of SWOG S0325, an intergroup randomized PHASE II trial in newly diagnosed chronic phase chronic myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 2, p. 223, doi. 10.1111/bjh.12618
- By:
- Publication type:
- Article
Sequencing small genomic targets with high efficiency and extreme accuracy.
- Published in:
- Nature Methods, 2015, v. 12, n. 5, p. 423, doi. 10.1038/nmeth.3351
- By:
- Publication type:
- Article
A graphical, interactive and GPU-enabled workflow to process long-read sequencing data.
- Published in:
- BMC Genomics, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s12864-021-07927-1
- By:
- Publication type:
- Article
Predictors of tyrosine kinase inhibitor adherence trajectories in patients with newly diagnosed chronic myeloid leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1842, doi. 10.1177/1078155220970616
- By:
- Publication type:
- Article
BCR::ABL1 digital PCR for treatment‐free remission prediction in chronic myeloid leukemia patients: An individual participant data meta‐analysis.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 8, p. 1632, doi. 10.1002/ajh.27359
- By:
- Publication type:
- Article
AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report.
- Published in:
- Biomarker Research, 2020, v. 8, n. 1, p. 1, doi. 10.1186/s40364-020-00208-1
- By:
- Publication type:
- Article
From molecular interaction to acute promyelocytic leukemia: Calculating leukemogenesis and remission from endogenous molecular-cellular network.
- Published in:
- Scientific Reports, 2016, p. 24307, doi. 10.1038/srep24307
- By:
- Publication type:
- Article
Combined Population Dynamics and Entropy Modelling Supports Patient Stratification in Chronic Myeloid Leukemia.
- Published in:
- Scientific Reports, 2016, p. 24057, doi. 10.1038/srep24057
- By:
- Publication type:
- Article
The Prognostic Significance of <i>IRF8</i> Transcripts in Adult Patients with Acute Myeloid Leukemia.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0070812
- By:
- Publication type:
- Article
Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients.
- Published in:
- Biomarker Research, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40364-023-00461-0
- By:
- Publication type:
- Article
Molecular Monitoring of Patients With Chronic Myeloid Leukemia: Clinical Examples From a Non-Trial Setting.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, p. S391, doi. 10.3816/CLM.2009.s.039
- By:
- Publication type:
- Article
Optimizing Timing of Secondary Tyrosine Kinase Therapy in Chronic Myeloid Leukemia.
- Published in:
- Clinical Lymphoma & Myeloma, 2008, v. 8, p. S89
- By:
- Publication type:
- Article
Emerging Strategies in the Management of Chronic Myeloid Leukemia.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 7, p. S50
- By:
- Publication type:
- Article
Monitoring Patients with Chronic Myeloid Leukemia Receiving Abl Tyrosine Kinase Inhibitor Therapy.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 7, p. S58
- By:
- Publication type:
- Article
Regulation of myeloid leukaemia by the cell-fate determinant Musashi.
- Published in:
- Nature, 2010, v. 466, n. 7307, p. 765, doi. 10.1038/nature09171
- By:
- Publication type:
- Article
Estimated Savings After Stopping Tyrosine Kinase Inhibitor Treatment Among Patients With Chronic Myeloid Leukemia.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 12, p. e2347950, doi. 10.1001/jamanetworkopen.2023.47950
- By:
- Publication type:
- Article
Association of immunophenotype with expression of topoisomerase II α and β in adult acute myeloid leukemia.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-62345-9
- By:
- Publication type:
- Article
Optical painting and fluorescence activated sorting of single adherent cells labelled with photoswitchable Pdots.
- Published in:
- Nature Communications, 2016, v. 7, n. 4, p. 11468, doi. 10.1038/ncomms11468
- By:
- Publication type:
- Article
Single-cell genotyping demonstrates complex clonal diversity in acute myeloid leukemia.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 281, p. 1, doi. 10.1126/scitranslmed.aaa0763
- By:
- Publication type:
- Article
Case Presentations: Allograft or Third-Line Therapy in Very Resistant CML.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S32, doi. 10.1016/j.clml.2019.07.409
- By:
- Publication type:
- Article
Treatment-Free Remission (TFR) Following Frontline Nilotinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): 192-Weeks Data from the ENESTfreedom Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S288, doi. 10.1016/j.clml.2019.07.232
- By:
- Publication type:
- Article
Clinical Effect of Combined Mutations in DNMT3A, FLT3-ITD, and NPM1 Among Egyptian Acute Myeloid Leukemia Patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
ENESTfreedom 144-Week Update: Long-Term Treatment-Free Remission (TFR) Following Frontline Nilotinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S226, doi. 10.1016/j.clml.2018.07.099
- By:
- Publication type:
- Article
Management of chronic myeloid leukemia in 2023 – common ground and common sense.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00823-9
- By:
- Publication type:
- Article
Management of chronic myeloid leukemia in 2023 – common ground and common sense.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00823-9
- By:
- Publication type:
- Article
Transferred WT1-Reactive CD8<sup>+</sup> T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients.
- Published in:
- Science Translational Medicine, 2013, v. 5, n. 174, p. 1, doi. 10.1126/scitranslmed.3004916
- By:
- Publication type:
- Article
Identification of genes with abnormal expression changes in acute myeloid leukemia.
- Published in:
- Genes, Chromosomes & Cancer, 2008, v. 47, n. 1, p. 8, doi. 10.1002/gcc.20500
- By:
- Publication type:
- Article
Emerging translational science discoveries, clonal approaches, and treatment trends in chronic myeloproliferative neoplasms.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase I/II multisite trial of optimally dosed clofarabine and low‐dose TBI for hematopoietic cell transplantation in acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. 48, doi. 10.1002/ajh.25665
- By:
- Publication type:
- Article
Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. E49, doi. 10.1002/ajh.24980
- By:
- Publication type:
- Article
Chronic myeloid leukemia 2011: Successes, challenges, and strategies-Proceedings of the 5th annual BCR-ABL1 positive and BCR-ABL1 negative myeloproliferative neoplasms workshop.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 9, p. 811, doi. 10.1002/ajh.22097
- By:
- Publication type:
- Article
Comprehensive evaluation of time-to-response parameter as a predictor of treatment failure following imatinib therapy in chronic phase chronic myeloid leukemia: Which parameter at which time-point does matter?
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 11, p. 856, doi. 10.1002/ajh.21850
- By:
- Publication type:
- Article
Impact of Minimal Residual Disease, Detected by Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia.
- Published in:
- Leukemia Research & Treatment, 2014, p. 1, doi. 10.1155/2014/421723
- By:
- Publication type:
- Article
An evolutionary explanation for the presence of cancer nonstem cells in neoplasms.
- Published in:
- Evolutionary Applications, 2013, v. 6, n. 1, p. 92, doi. 10.1111/eva.12030
- By:
- Publication type:
- Article
Monitoring of TKI-Resistant Chronic Myeloid Leukemia.
- Published in:
- Clinical Advances in Hematology & Oncology, 2014, v. 12, p. 3
- By:
- Publication type:
- Article
The Role of Transplant in CML.
- Published in:
- Clinical Advances in Hematology & Oncology, 2013, v. 11, n. 11, p. 11
- By:
- Publication type:
- Article
Chronic myeloid leukemia: Global impact from a local laboratory.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Measuring response to BCR-ABL inhibitors in chronic myeloid leukemia.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Measuring response to BCR-ABL inhibitors in chronic myeloid leukemia.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 2, p. 300, doi. 10.1002/cncr.26280
- By:
- Publication type:
- Article
Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2010, v. 151, n. 5, p. 430, doi. 10.1111/j.1365-2141.2010.08387.x
- By:
- Publication type:
- Article